LGND Competitors & Alternatives
Compare Ligand Pharmaceuticals Incorporated with similar stocks in the same industry
Biotechnology
LGND
Main Stock$292.04
Tradestie Score
57
Market Cap
$3.49B
P/E Ratio
37.6
Revenue Growth
0.1%
Analyst Upside
+10.7%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CYTK
Cytokinetics Inc.
|
$76.45
|
$6.68B | - | 60 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$102.78
|
$6.64B | - | 60 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$124.78
|
$6.38B | - | 57 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$19.01
|
$6.03B | - | 54 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$49.57
|
$6.02B | - | 53 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 57 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$211.04
|
$5.92B | - | 54 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$46.17
|
$5.80B | 18.2 | 60 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$312.57
|
$5.20B | 45.7 | 59 | Compare |
|
ALKS
Alkermes Inc. plc
|
$49.53
|
$5.06B | 128.9 | 58 | Compare |
More LGND Analysis
Data updated: Aug 04, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry